IONS
IonisCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
IONS vs peer average
44/100
IONS vs. peer average (C vs. C)
Grade spread
A 2 · B 3 · C 4 · D 1 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ALNY is the first available peer comparator.
RNA-targeting therapeutics developer; comparable technology focus and investor sensitivity to clinical readouts.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IONS
Ionis
ALNY
Alnylam
Grade
C
B
Momentum
47
19
Value
41
58
Sentiment
69
95
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs ALNY
IONS / ALNY
Grade Position
Below peers
IONS vs. peer average (C vs. C)
44/100
Momentum
47
IONSValue
41
ALNYSentiment
69
ALNYRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IONS
ALNY is the first peer returned for this comparison set.